Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Excellent commentary gentlemen!! I just caught up on today's posts and very much appreciate the efforts!
Good call Cyosol and DRK!
I preferred the "non-dilutive" funding (i.e. NIH grants) that was specifically referenced on the investor call. Although, I found it interesting that some of what we all heard was omitted from the written transcript of the call that was released.
This isn't that bad in a relative sense, oh well, onward and upward!
I'm with RC, if they did your scenario, it would piss me off... This company is still way undervalued...
Yeah, I was wondering if we would see a move like last January, and here we are...
Even at $3, the market cap is ONLY around $15 million, I don't think we'd be undervalued at $10/share...
Thanks RC! That reads exceptionally well! It seems our little $5 million company exists in a black hole and is invisible to the broad investor community...
Echoing Runncoach and Cyosol, that was a very positive call, all things considered!
Potential additional NIH grant money, other indications and partnerships, no near term need for dilutive capital raising... It is utterly ridiculous that our market cap is approximately $5 million right now, IMHO, I could easily justify this company having a $100 million market cap right now...
I'm surprised at the sell-side supply of shares holding the price to $1.10 today... I hope that we are not going to learn about an equity raise at a price point below the current cash value of the company... I'm hopeful about tomorrow's call but I don't trust Silverman.
Excellent, thanks!!!
I believe that is good approximation RC!
Great! Your account had access to trade SNPX before mine so maybe Fidelity is just a couple days behind TD??
Has anyone's spin-off shares actually showed up as SNPX listed shares at their current value in your accounts??
My shares are still a journal entry with no ticker or value associated yet...
SNPX can now be purchased on Fidelity.
I picked up 5,000 shares at an average price of $1.19 and drove the price up to $1.25. I'm happy to buy more but this market is very slow and inefficient right now...
My spin-off shares are still merely a journal entry and are not yet reflecting the new ticker or value.
I'll check, I've got to believe that we can trade pink sheet stocks, it may be that it was a new listing and there was no information available on it. Hopefully that resolves...
I still can't access a purchase of SNPX on the Fidelity platform and Fidelity might be the largest broker in the country so what does that mean in terms of restricted market for this stock as of today??
Also, my spin-off shares are still merely a journal entry with no listing of ticker or value. IMHO, once, the broader market opens for this stock, there will be a solid correction upward in price.
As I mentioned yesterday, I think anything below $1.50 is a stone cold no-brainer, and I'd even say $1.50-2.00 is still a great buy! If I could participate right now, my purchases would move the price up so I guess we'll have to wait and see as this opens up...
Excellent!!!
Tried to buy SNPX with Fidelity on the phone, it is simply not available to trade on any of their platforms. Apparently there are control rules in place with a pink sheet new listing with no available information, they don't do it nor allow it...
Hopefully this is lifted soon as I'd love to buy at these absurdly low prices right now...
Agreed, wishful, but logical. At a certain point, I'd like to think our stewards of NTRP are making sound decisions on our behalf... Also, wishful thinking... :)
Haven't we all wondered why big pharma wouldn't be interested in getting in at a price well above current market? For a hypothetical example, they could jump in with $50 million for 50%? That would be a rounding error to them, with massive upside... In reality, NTRP management would not have done a deal like that prior to 9/19, but now???
I've wondered if the spin-off is cleaned up to either sell or partner with big pharma?? If that is the strategy, then it actually makes sense to offload most of the cash and the listing beforehand...
Congrats on the purchase! I could probably call into Fidelity's service line and they could run a trade through their house traders...
I can't imagine they would raise equity at a price point below the tangible assets of the company. That said, with Silverman, you never know...
The current price today is meaningless as most investors can't access the market yet... IMHO, I stand by an opinion that the base price should be $1.50/share, and I doubt there is much sell side supply below that...
I tried to buy some SNPX at the current low price point but couldn't with the error message "Error:(TC9052) Opening transactions for Pink Sheets (without information) are not permitted because of the risks associated with these securities and all Microcap securities."
Today's pricing is extremely inefficient. Frankly, IMO, anything below $1.50 is a no-brainer BUY, as the market opens up for this stock, I expect the trading to land in the $1.50-2.00 range and in the not so distance future, will be trading above $2.00, IMHO...
Me too, great name! BTW, my shares just showed up as a journal entry with Fidelity, no ticker listed but at least I can see them and it is the count I was expecting...
Thanks for the ticker (SNPX), looks like VERY light trading at $1.74 current price.
My shares are not showing up yet in my Fidelity account, hopefully they pop in today...
No NBI in the account today, hopefully tomorrow...
Exactly, this is very exciting news as the trial is advancing faster than expected!
Trial enrollment is up to 20 and is going very well, much better than expected in the Covid environment!
Darn, I screwed that up, I meant 1 for 5.
Confused with 5 to 1, lol...
NBI will have all of the NTRP assets, except that Nasdaq listing and $20 million in cash. So, remaining cash, NIH grant, most importantly Alkon, all patents and license agreements, etc. Oh, a bonus is we lose Charles Ryan!
I believe that NBI will show up this coming Monday, I'm not sure if initially it will be merely a journal entry or if the shares will be ready to trade. If not Monday, I'm guessing they'll be ready to trade by Tuesday...
I think we should be worth at least $1.50/share (after 5 for 1 split) and I'm guessing we'll trade between $1.50 and $2.00 initially... It will be a tighter market with very little short selling available and I think those of us that have it, want it, and so if anything, demand should be stronger than supply...
I use Fidelity as well. The values are now reflected in the account today.
My shares were only listed as a journal entry with just share total (reflecting 5 for 1 split) but no values and they were not available for trade. I did watch the trading today and it did land in the range I expected post-spin-off... Hopefully tomorrow, our accounts are properly reflecting tradable shares...
PTPI just showed up in my account with the conversion (1 for 5 shares). Light early trading with a Bid-Ask of $4.34-$4.78 (.868-.956)... Accounts are being updated and the new Ticker is being added, so trading volume should pick up...
I completely understand and agree, I just expected today's price to be around $.75-.80... Very surprised and happy to get what I got for it...
Ex-Spinoff Date Pricing???
I'm experiencing cognitive dissonance and wondering, what am I missing??
I get that this is a thinly traded stock and is subject to timeframes of irrational and inefficient pricing, but there is in essence ZERO impact to the share price for a new company that does not include the NBI spin-off, that was included yesterday??
I was actually tracking this pre-market looking for an indication and thinking I'd like to be in front of expected selling today, but when I put my first (of many) tranches of 10,000 shares SELL orders in at the open, I was surprised to get $1.03. Admittedly, I'm the reason the stock fell to .94 this morning, but it absorbed a lot of hits to get there. And, has continued taking hits this afternoon (I'm more than 50% of the volume) but the price has held right at the $1.00 mark.
FWIW, I think the spin-off shares are worth at least $.30 per share ($1.50 after the 1 for 5 split) and I'd be very surprised if they traded below this point once they are on the OTC market.
As far as Petros, I'm keeping a little of it, more as a curiosity to see if they can get Stendra sold over the counter and what that potential could mean with several years of the patent left. Our NTRP cash contribution to Petros is about $.84 and obviously there is value in the shell and listing, but that said, I'm thrilled to get a buck out of the shares I sold...
Makes sense, we're in this together!
A rare disagreement with you Runncoach. IMHO, right now, at the absurdly low price of $.91, is a great time to buy! Trading well below cash and then I would certainly understand a strategy to buy now, then sell shares after the Record date.
To me, the real criticism of the strategy would go back to last spring with the merger announcement (and arguably the capital raise before that), because frankly, this stock would probably be trading for over $2. But, at this depressed price, it's hard for me to think that the bankers were so incompetent in structuring the deal (was reconfigured to 49%) that we shouldn't get at least our prorata cash once the merged company is trading.
I'm not certain that I'm selling my shares of the merged company, or at least all of them, I'll reassess post merger and then make the call... But, I'm very happy to carry the exceptional risk/reward proposition with the spin-off shares... It will be interesting to see how this stock trades pre and post Record date...
IMHO, it is irrational to trade below cash and while I have no idea of what the proper value of the new company should be, I'm expecting our 49% interest to trade at no less than our pro-rata cash contribution, and beyond that, the shell and listing clearly has added value.
I'm GUESSING that there will be a price run-up prior to the ex-date and this might give us a better idea of how the two pieces will look after the split. Frankly, it's hard for me to think we won't "correct" to cash, at least by the ex-date.
As far as irrational pricing, we are indeed a micro-cap and there just aren't many of us unique shareholders, so a disparate balancing of supply and demand in daily trading creates opportunities for those of us true believers or even value minded speculators...
Thanks RC, it seems it has to be???
I purchased 20,000 shares of NTRP on 9/28 with a settlement date of 9/30. If these shares are not counted for ownership interest in the spin-off Neurotrope entity, I will file a lawsuit...
IMHO, it is incomprehensible that they would announce a shareholder of record date well after the date...
My account doesn't have the prospectus yet so I'm wondering if the document we are looking at is still a working document and not final???
There was massive volume on 9/30, perhaps large holders trading among themselves through the market, obviously some got out. I'm embarrassed that I completely missed what was going on at the time...
EDIT: I just realized that this is the proxy and is something that I haven't seen before. I haven't received my prospectus yet...